06Jun

Almost a century ago the comic strip hero Popeye popularized spinach, attributing his amazing strength to the leafy green. Within a few short years of Popeye’s first appearance in 1929, spinach sales soared.

Now, spinach has a new claim to fame. Biologists are using microscopic parts of the plant to speed up photosynthesis, the process of using light to convert carbon dioxide into energy and oxygen.

Still limited to laboratory research, the implications of the research, published this month in Science, are profound. The faster process — up to 100 times faster — could be harnessed to manufacture drugs, accelerate the growth of crops and even help fight climate change.

Tobias Erb, a synthetic biologist at the Max Planck Institute for Terrestrial Microbiology and a lead researcher on the project, said his team expects to be able to modify the output of their photosynthesis process to produce different types of organic compounds, including drugs.

By engineering the new photosynthesis into agricultural crops, they could go from seedling to harvest in far less time, enabling farmers to produce more food than is now possible.

One particularly intriguing possibility is to use this new, faster photosynthesis process to help fight climate change by enabling plants to absorb up to 10 times more carbon dioxide than they do naturally.

“Artificial trees, that’s a cool idea,” Erb told the online magazine Inverse.

Erb and the research team caution that much work remains before the process can be scaled – right now the artificial structure degrades after just a few hours.

“In the natural system there are automatic repair systems,” Chemical & Engineering News quotes Erb as saying. “In our system that is not possible yet.”

Nevertheless, bioscientists not involved with the research, see it as a major step forward.

“It’s a profound discovery,” says Paul King, a physical biochemist at the National Renewable Energy Laboratory in Golden, Colorado.

Declaring it “very ambitious,” Frances Arnold, professor of chemical engineering, bioengineering and biochemistry at the California Institute of Technology, predicted the work will improve current efforts to convert carbon dioxide directly into useful chemicals.

Photo by Louis Hansel @shotsoflouis on Unsplash

[bdp_post_carousel]

Jun 6, 2023

Seattle’s Biotech Is Desperate For Workers

One of the nation’s premier biotech centers is finding it so hard to fill jobs the state’s trade association has launched an ambitious marketing campaign to lure workers to Washington state.

“Our industry has jobs. We have jobs at all levels,” said Leslie Alexandre, CEO of the trade group Life Science Washington. “We eagerly welcome people to come and join our ecosystem or to be trained from our schools and colleges.”

The organization hopes to entice workers with a flashy campaign designed to sell the Seattle lifestyle and promote the industry. Life Science Jobs in Washington State, launched last week, with the tag line: “Do your best work. Live your best life.”

In photos, videos and text, the site showcases the Seattle area’s environment and its life sciences industry. The videos have biotech workers telling their stories, extolling the significance of the work they do and the livability of the state. The idea is to introduce the rest of the country to what the state and especially the Puget Sound area has to offer.

Outside the Northwest, said Alexandre, people “simply do not know what Washington is about it.”

The site’s FAQ reinforces the sell. Discussing the cost of living, the site says it’s lower than in “many other life science clusters.,” Industry pay is competitive. The site pitches strongly to families, declaring, “high-ranked schools, abundant parks and excellent healthcare make it one of the best states in the country to raise happy, healthy children.”

Among the initial 217 jobs, the majority are at a senior level, requiring an advanced degree and several years of experience in life sciences. There are, however, several jobs for IT professionals and others, including some mid-level opportunities.

Meg O’Conor Bannecker, public affairs consultant working with Life Science Washington, told the Puget Sound Business Journal the area has a “a growing need for these middle-skill workers.”

She said entry-level jobs in biomanufacturing pay about $42,000, rising to as much as double after only a few years.    

Photo by National Cancer Institute on Unsplash

[bdp_post_carousel]